Primary care trusts are legally required to make funding available for drugs and treatments recommended by the National Institute for Health and Clinical Excellence (NICE) as part of a technology appraisal within three months of NICE'S final guidance being published. Patients also have a right to receive such treatments, where clinically appropriate, under the NHS Constitution. There is a small number of technology appraisals for which this legal requirement has been waived or amended.